Zhang R, Hu X, Khant H, Ludtke SJ, Chiu W, Schmid MF, Frieden C, Lee JM. Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM. Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4653-8. PubMed.
Recommends
Please login to recommend the paper.
Comments
NIDDK, NIH
1. Before comparing structural studies of Aβ fibrils from different laboratories, it is crucially important to compare the conditions under which the fibrils were grown, as our own solid-state NMR and electron microscopy studies have shown that Aβ fibril structures depend strongly on growth conditions. In the recent cryoEM studies by Zhang et al., the fibrils were grown at 37 C in 10 mM HCl. In our solid-state NMR studies, fibrils were grown at room temperature in pH 7.4 buffer.
2. The Aβ1-40 and Aβ1-42 peptides apparently adopt quite similar molecular conformations in amyloid fibrils, and both form parallel β-sheets, based on solid-state NMR, H/D exchange, and other data. But other aspects of the fibril structures may be somewhat different. Structures of Aβ1-42 fibrils have not yet been characterized completely by solid-state NMR.
3. The most surprising aspect of the cryoEM reconstruction reported by Zhang et al. is the central pore in the Aβ1-42 fibril structure. Structural models for Aβ1-40 fibrils based on solid-state NMR and electron microscopy (especially scanning transmission electron microscopy) do not contain such a large pore. Solid-state NMR data for Aβ1-40 fibrils indicate intermolecular contacts that would be inconsistent with the cryoEM results of Zhang et al. But again, the experiments of Zhang et al. were performed on Aβ1-42, rather than Aβ1-40, and the pH and temperature during fibril growth were quite different.
4. Finally, the Aβ1-40 peptide (and possibly also the Aβ1-42 peptide) can probably form five or six different fibril structures. It will be interesting to identify the structure or structures that develop in the human brain. This is one of the goals of our own current work.
View all comments by Robert TyckoMax-Planck Research Unit for Enzymology of Protein Folding
Zhang at al. report a three-dimensional reconstruction of an Aβ1-42 amyloid fibril based on cryoelectron microscopy data. The obtained structure varies very significantly from the fibril structure that our groups have published for Aβ1-40 peptide. This does not only hold for the Aβ1-40 structure quoted by the authors (Sachse et al., 2006; Sachse et al., 2008). It is also true for a very recently published analysis of the structure of 12 Aβ1-40 amyloid fibrils (Meinhardt et al., 2009) None of them are similar to the Aβ(1-42) fibril structure reported here.
The now published Aβ1-42 fibrils were obtained by in-vitro incubation of pure peptide at pH 2.0 for four weeks. Incubation at strongly acidic conditions and for a prolonged time is generally known to lead to peptide fragmentation or other covalent modifications. Furthermore, different pH values can lead to dramatically different fibril structures. Therefore, it is possible that the analyzed fibrils differ quite substantially from the ones that are present in Alzheimer patients and that are formed, of course, under physiologically relevant pH conditions.
It would be helpful if the manuscript provided more of the technical information that a reader would like to know for judging the reliability of this new Aβ1-42 structure and whether it truly reflects the structure of the analyzed fibrils. For example, comparisons between the raw images obtained in the electron microscope and projections of the structure are not included. No statistical analysis of the different observed fibril symmetries is shown. No mass-per-length measurements were carried out to support the interpretation of the structure with two peptides in cross-section. It is not clear to us why the published structure does not show more structural detail despite its resolution of 10 angstroms. In the light of these concerns, the presented structural model remains speculative at this point, and its relevance for Alzheimer disease remains to be further clarified.
References:
Sachse C, Xu C, Wieligmann K, Diekmann S, Grigorieff N, Fändrich M. Quaternary structure of a mature amyloid fibril from Alzheimer's Abeta(1-40) peptide. J Mol Biol. 2006 Sep 15;362(2):347-54. PubMed.
Sachse C, Fändrich M, Grigorieff N. Paired beta-sheet structure of an Abeta(1-40) amyloid fibril revealed by electron microscopy. Proc Natl Acad Sci U S A. 2008 May 27;105(21):7462-6. PubMed.
Meinhardt J, Sachse C, Hortschansky P, Grigorieff N, Fändrich M. Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J Mol Biol. 2009 Feb 27;386(3):869-77. PubMed.
View all comments by Marcus FandrichBrookhaven National Laboratory
Aβ40 and Aβ42 are 40- and 42-residue peptides produced by the sequential cleavage of amyloid precursor protein by β-secretase and γ-secretase. The peptides have a strong tendency to self-aggregate, initially into soluble oligomers, and eventually into insoluble fibrils and large neuronal deposits. Although the soluble oligomers are considered the major culprit of neuronal toxicity, there is nevertheless strong interest in the structure of the Aβ fibrils. Aβ fibrils have been a longstanding subject of various biophysical studies, including cryoEM. Nevertheless, the cryoEM structure of Aβ42 fiber at 10-angstrom resolution as reported by Lee and colleagues represents a significant step forward in our pursuit of the structural basis of Aβ peptide fibrillization. The new structure reveals the expected two protofilaments twisted along the fiber axis. The novelty of the new structure is that the β-sheets are arranged at the periphery surrounding a hollow core, thus forming a long tube-like structure. This architecture is drastically different from the fiber structure formed by Aβ40 peptide, also determined by cryoEM, in Niko Grigorieff’s lab at Brandeis University, Waltham, Massachusetts, and reported previously (Meinhardt et al., 2009; Sachse et al., 2008). In the Aβ40 fiber, the β-sheets are arranged radially, twisting along the helical axis to form the long fiber with a solid core. As Aβ fibers are highly heterogeneous and polymorphic, it will be interesting to find out whether the structural differences observed in these studies merely reflects the peptide constituents (i.e., Aβ40 versus Aβ42) of the particular species of fibers selected for 3D reconstruction, or whether the structural differences represent a true defining feature of two functionally different peptides (i.e., Aβ40 is significantly less toxic than Aβ42).
The new cryoEM map by Zhang et al. fits the cryoEM micrograph well and appears solid. Furthermore, the structure model derived from the cryoEM map is supported by their extensive proteolysis data. Nevertheless, the interpretative model shall be taken with a grain of salt. Since the accurate mass per unit length of Aβ42 fiber is not known in this case, the display threshold for surface-rendering of the cryoEM map has to be somewhat artificial. The choice of threshold would thus have implications in building the structural model. I also want to point out that the proteolysis data, although supportive of their model, is not in conflict with a previous model that involves inter-β-sheets interaction (Sato et al., 2006). In summary, my impression is that there is a need for understanding the structural basis of Aβ peptide fibrillization. The current work might not be the final elucidation of such mechanism, but is a significant step forward in the long quest.
References:
Meinhardt J, Sachse C, Hortschansky P, Grigorieff N, Fändrich M. Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J Mol Biol. 2009 Feb 27;386(3):869-77. PubMed.
Sato T, Kienlen-Campard P, Ahmed M, Liu W, Li H, Elliott JI, Aimoto S, Constantinescu SN, Octave JN, Smith SO. Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42. Biochemistry. 2006 May 2;45(17):5503-16. PubMed.
View all comments by Huilin LiCryoEM-determined structures of Alzheimer’s peptide Aβ1-42 reveal significant differences between the fibrils of this peptide and the other most-studied Alzheimer’s peptide, Aβ1-40. Thus, they extend the known differences in kinetic, thermodynamic, and dynamic properties of these two peptides observed in solution to the supramolecular architecture of fibrils formed by them.
One of the significant points of this study is that fibrils formed by Aβ1-42 have a hollow core in contrast to those formed by Aβ1-40. At a cross-sectional plane, each protofilament accommodates a single molecule of Aβ1-42 in a hairpin-like conformation while two Aβ1-40 peptides are present in extended conformation in their respective fibrils. Structures of both fibrils were determined to the same resolution (~10 angstrom vs. ~8 angstrom); therefore, the differences can’t be attributed to the differences in experimental data collection.
However, fibril morphology is highly dependent on growth conditions. Under a variety of growth conditions, a different conformation from an ensemble of conformations may prevail under a given set of conditions for each peptide. Nevertheless, data shown in this work are consistent with the differences observed between the two peptides in solution studies. They remind us that we still don’t know the nature of molecular interactions that affect these two similar peptides such that they can behave so differently in solution leading to significantly different consequences.
One of the common points between the EM structures of both peptides is that both structures suggest protofilaments are joined through the flexible N-terminal residues of both peptides, which also agree with the solution studies. Thus, it is very likely that dynamic properties of these peptides (i.e., switching between various conformations and their thermodynamic consequences) play a significant role in determining how the individual peptides form the initial complex and extend it to a protofilament and fibril level. This would allow small differences to be amplified, yielding significant kinetic and structural differences in fibrils of the same peptide or between the fibrils of the two peptides.
View all comments by Engin SerpersuMake a Comment
To make a comment you must login or register.